March 15, 2000Solvay Pharmaceuticals, Inc.
Recalls Lithobid Slow Release Tablets
Marietta, GA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Solvay Pharmaceuticals, Inc. is recalling
Lithobid Slow Release Tablets because of dissolution failure at stability testing.
Over 14,000 of the recalled Lithobid
Slow Release Tablets, (Lithium Carbonate, USP), in 300 mg bottles of 100, were distributed
nationwide and bear the Lot Number 90573.
This ongoing Class II recall
was initiated by Solvay Pharmaceuticals, Inc. by letter dated January 18, 2000. This
is the first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-243-0
Notice of this product warning was
sent via email to SafeMail
subscribers March 15, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.